Still looks overbought after the breakout of the ascending channel
. Needs to do some work in the upper channel and I suspect that $7.50 or so should be a nice entry point. Again, another stock I like for a buy and hold. Boob jobs are the rage and this company has filled the size gaps where Mentor and Allergan have been deficient. Business was up big this year and with a strong consumer 2020 should be a solid year for implants.